Brevilin A

Brevilin A has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 30, 2022: “Brevilin A enhances innate immunity and the resistance of oxidative stress in Caenorhabditis elegans via p38 MAPK pathway”.

Intervention

1 paper studies it5 findingsUpdated

PubChemMeSH

See all 1 papers on brevilin A

At a glance

The findings reach worms or flies, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Worms or flies: a single group. Cells, mice and humans: nothing yet.
  • 1 lab in 1 country
  • Funder: National Natural Science Foundation of China
  • Model organisms1

What did studies of brevilin A find?

5

Studies of brevilin A measured 5 outcomes, among them lifespan, oxidative stress and ROS signaling and pmk-1.

Lifespan

upin worms1

1 study
  1. Brevilin A extends lifespan in worms.

    Model organisms

Oxidative stress and ROS signaling

downin worms1

1 study
  1. Brevilin A protects against oxidative stress and ROS signaling in worms.

    Model organisms

More on Oxidative stress and ROS signaling

pmk-1

upin worms1

1 study
  1. Brevilin A activates pmk-1 in worms.

    Model organismsintestine

More on pmk-1

Bacterial burden

downin worms1

1 study
  1. Brevilin A decreases bacterial burden in worms.

    Model organismsintestine

Bacterial infection

downin worms1

1 study
  1. Brevilin A protects against bacterial infection in worms.

    Model organisms10 μM

More on Bacterial infection

Latest